Vol. 1 Issue 09    Friday, November 9, 2007 “Visit us at CPhI India 2007, at Bombay Exhibition Centre, Mumbai, India. November 25 - 27  2007, at Hall- 5, Stand No: B12”   APIs    Commercial Scale  Alendronate sodium  Arteether  Artemether  Artesunate  Azithromycin  Cetirizine dihydrochloride  Chloramphenicol palmitate  Clopidogrel bisulphate  Coenzyme Q10  Dihydroartemisinin  Erythromycin base  Erythromycin estolate  Erythromycin ethyl succinate  Erythromycin oxime (intermediate)  Erythromycin phosphate  Erythromycin propionate  Erythromycin stearate  Isoniazid  Lisinopril dihydrate  Losartan potassium  Pyrazinamide  Rifampicin  Roxithromycin  Sodium valproate  Valproic acid  Venlafaxine hydrochloride  Zoledronic acid  Zopiclone  Pilot Plant Scale  Carvedilol  Clarithromycin  Pioglitazone hydrochloride  Rosiglitazone maleate  Valsartan  R & D Scale  Lumefantrine  Pamidronate disodium  Perindopril erbumine  Zolpidem tartrate  Development  Benazepril hydrochloride  Candesartan  Desvenlafaxine  Glipizide  Irbesartan  Levocetirizine  Rifabutin  Rifapentine  Ramipril  Risedronic acid  Telmisartan       Product under patent  offered  only       for exempted research, clinical and       development  purposes. Only  non-       infrining   products   and  processes       are offered, subject to patent status       verification by client. Services    • Custom Syntheses    • Contract Manufacturing    • FTE Research    • Analytical Support    • Intermediates & APIs    • Building Blocks Calyx has successfully crossed another mile stone ……. Safety, health & environmental excellence has   always been Calyx’s corporate  commitment. We earned  ISO 14001 recognition for  Environmental  Management  System in  October  2007 from  Bureau Veritas Certification. The  certification was  achieved in record time and the whole certification process took  just seven  months  from initial  implementation to  formal  recognition  from Bureau  Veritas Certification. Calyx is now proud to be amongst a few API companies in India which are certified to this stringent environmental standard. The  certification  process involves listing  of  all activities, products & services  which  we can control or  which we can influence. Environmental  aspects and  associated  impact of  these  activities are  further  assessed to  decide the significance. Significant environmental aspects are either controlled by  stringent monitoring or their impacts are  reduced through planned  environmental management  programmes. Periodic  evaluation  of  compliance to  applicable  legal requirements is an  important  feature  to be accomplished for this certification. ISO 14001:2004 is the internationally  recognized standard  for Environmental  Management Systems. It provides a framework for managing  environmental  responsibilities so they  become more efficient and more  integrated  into overall  business  operations. This certification has enhanced our commitment & responsibilities towards environment and now onwards continual improvement in environmental performance would be our way of life. SHE Policy   Disclaimer:  "The information in this e-mail and any attachments is confidential and may be legally privileged. It is intended solely for the addressee or addressees. If you are not an intended recipient, please delete the  message and any   attachments and notify the sender of  misdelivery. Any use or disclosure of  the  contents of either is unauthorized  and  may   be unlawful. All  liability  for viruses is excluded to the fullest   extent permitted by law. Any views   expressed in this message  are those of the individual sender, except where the sender   states them, with requisite authority, to be those of the specific Calyx company." To unsubscribe from this Newsletter send blank email to pharmanews@calyxindia.com  “Meet us at CPhI India  2007, at Bombay Exhibition Centre, Mumbai, India. November  25 -  27  2007, at Hall- 5, Stand No: B12”